Persistent risk of vascular complications and efficacy of prolonged dual antiplatelet therapy after myocardial infarction
The article discusses data on the duration of risk retention and the main cause of vascular complications in patients with acute coronary syndrome. Preconditions for prolonged use of dual antiplatelet therapy after myocardial infarction are presented. The authors consider the results of a large, pro...
Main Author: | I. S. Yavelo |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«REMEDIUM GROUP» Ltd.
2022-01-01
|
Series: | Атеротромбоз |
Subjects: | |
Online Access: | https://www.aterotromboz.ru/jour/article/view/253 |
Similar Items
-
ПРЕДОТВРАЩЕНИЕ ПОВТОРНЫХ ИШЕМИЧЕСКИХ СОБЫТИЙ У БОЛЬНЫХ, ПЕРЕНЕСШИХ ИНФАРКТ МИОКАРДА. НОВЫЕ ВОЗМОЖНОСТИ ДЛИТЕЛЬНОЙ ДВОЙНОЙ АНТИТРОМБОЦИТАРНОЙ ТЕРАПИИ. ПО РЕЗУЛЬТАТАМ ИССЛЕДОВАНИЯ PEGASUS-TIMI 54
by: О. В. Аверков
Published: (2015-07-01) -
DURATION OF DUAL ANTIPLATELET THERAPY
by: O. L. Barbarash
Published: (2016-07-01) -
ДВОЙНАЯ АНТИТРОМБОЦИТАРНАЯ ТЕРАПИЯ: НЕОБХОДИМОСТЬ ПРИВЕРЖЕННОСТИ К ЛЕЧЕНИЮ И ВОЗМОЖНОСТИ ЕЕ ПОВЫШЕНИЯ
Published: (2014-12-01) -
SOME ASPECTS OF IMPROVING ADHERENCE TO DUAL ANTITHROMBOTIC THERAPY AFTER ACUTE CORONARY SYNDROME
by: A. D. Erlikh
Published: (2017-05-01) -
Compliance to preventive aspirin therapy in patients after acuter myocardial infarction. ACT Study results
by: V. M. Gorbunov
Published: (2010-10-01)